We are live on
!
Find out more
RCM
Ratan Capital Management Portfolio holdings
AUM
$269M
1-Year Est. Return
45.74%
This Fund
S&P 500
This Quarter
Est. Return
+13.11%
1 Year Est. Return
+45.74%
3 Year Est. Return
+319.5%
5 Year Est. Return
+357.06%
10 Year Est. Return
+4,150.52%
AUM
$450M
AUM Growth
+$380M
(+541%)
Cap. Flow
+$359M
Cap. Flow
% of AUM
79.68%
Top 10 Holdings %
Top 10 Hldgs %
59.77%
Holding
43
New
32
Increased
6
Reduced
1
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$38.6M |
| 2 |
Avantor
AVTR
|
+$12.9M |
| 3 |
Netflix
NFLX
|
+$11.4M |
| 4 |
PayPal
PYPL
|
+$10.9M |
| 5 |
Zoom
ZM
|
+$10.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elastic
ESTC
|
+$1.86M |
| 2 |
ARCE
Arco Platform Limited Class A Common Shares
ARCE
|
+$1.78M |
| 3 |
Simply Good Foods
SMPL
|
+$435K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.5% |
| 2 | Healthcare | 10.34% |
| 3 | Financials | 6.46% |
| 4 | Communication Services | 4.12% |
| 5 | Consumer Discretionary | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Atlassian
TEAM
$25.6B
| $5.83M | 1.3% |
+44,600
| New | +$5.37M |
|
27
CALL
Bank of America
BAC
$435B
| $5.8M | 1.29% |
+200,000
| New | +$5.77M |
|
|
DAY
28
DELISTED
Dayforce
DAY
| $5.23M | 1.16% |
104,104
| – | – |
|
|
XLNX
29
DELISTED
Xilinx Inc
XLNX
| $5.07M | 1.13% |
+43,000
| New | +$5.01M |
|
30
Adaptive Biotechnologies
ADPT
$3.59B
| $4.59M | 1.02% |
+95,000
| New | +$4.21M |
|
31
Thermo Fisher Scientific
TMO
$213B
| $4.17M | 0.93% |
+14,200
| New | +$3.91M |
|
|
32
Elastic
ESTC
$6.84B
| $4.16M | 0.93% |
55,773
-22,766
| -29% | -$1.86M |
|
33
RingCentral
RNG
$4.66B
| $3.94M | 0.88% |
+34,273
| New | +$3.95M |
|
34
Danaher
DHR
$137B
| $3.57M | 0.79% |
+28,200
| New | +$3.34M |
|
|
NVRO
35
DELISTED
NEVRO CORP.
NVRO
| $3.53M | 0.78% |
54,391
+15,738
| +41% | +$980K |
|
36
Zscaler
ZS
$24.5B
| $3.07M | 0.68% |
+40,000
| New | +$2.85M |
|
37
ICICI Bank
IBN
$108B
| $2.31M | 0.51% |
+183,500
| New | +$2.13M |
|
38
Global Payments
GPN
$23B
| $2.27M | 0.5% |
+14,177
| New | +$2.11M |
|
39
BridgeBio Pharma
BBIO
$15.7B
| $1.62M | 0.36% |
+60,000
| New | +$1.64M |
|
40
CALL
uniQure
QURE
$3.03B
| $1.56M | 0.35% |
+20,000
| New | +$1.27M |
|
|
CCC.WS
41
DELISTED
Clarivate Analytics Plc Warrants, each to purchase one Ordinary Share
CCC.WS
| $1.43M | 0.32% |
300,000
+200,000
| +200% | +$745K |
|
|
42
Simply Good Foods
SMPL
$901M
| – | – |
-21,135
| Closed | -$435K |
|
|
ARCE
43
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| – | – |
-55,000
| Closed | -$1.78M |
|
Similar funds
UHC
TWM
AFG
WIM
SWAG
BIM
PWM
SSWM
Ratan Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Ratan Capital Management held 43 positions worth $450M, up 541% from $70.3M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Ratan Capital Management deployed $359M of net new capital in Q2 2019, opening 32 new positions and adding to 6 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 134,000 shares worth $39.3M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 86% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Elastic, an estimated $1.86M trimmed.
- Ratan Capital Management's largest Q2 2019 buy was State Street SPDR S&P 500 ETF Trust: 134,000 shares worth $39.3M.
- Ratan Capital Management added most to Twilio in Q2 2019, an estimated $6.32M increase.
- Ratan Capital Management's biggest Q2 2019 reduction was Elastic, cutting an estimated $1.86M.
- Ratan Capital Management fully exited Arco Platform Limited Class A Common Shares in Q2 2019, selling an estimated $1.78M.
- Ratan Capital Management's ten largest holdings make up 60% of its $450M portfolio in Q2 2019.
- Ratan Capital Management opened 32 new positions and closed 2 in Q2 2019.
- Ratan Capital Management's portfolio value rose 541% quarter-over-quarter to $450M.
Based on Ratan Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.